Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Aug 23, 2019 1:30pm

91 Views

Post# 30059403

RE:Stock rollback is a very dumb idea

Newdaydawning ... Great post. You simply debunked the irrationality of our amateure fear-mongers.

_______________

newdaydawning - (8/23/2019 8:58:59 AM)
Stock rollback is a very dumb idea

TLT has acknowledged that the addition of as many as 115M shares (including warrants) creates more liquidity. A reverse split, by definition, would considerably restrain liquidity.

Stock consolidations rarely, if ever, work.

IMHO, the company can grow the price organically without the need for a reverse split.

And forget the NASDAQ for now. The first order of business is to uplist to the TSX, according to TLT's CFO.

Only fools would advocate a reverse split at this point.

Bullboard Posts

Silvercorp to expand into Ecuador with C$200M Adventus acquisition